Rak, A Ya <br/><br/>
[Mullerian inhibiting substance type II receptor as a potential target for antineoplastic therapy].  [electronic resource] 

 -  Biomeditsinskaia khimiia  Apr 2019 
 - 202-213 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2310-6972 
<br/><br/><label>Standard No.: </label>10.18097/PBMC20196503202  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Humans<br/>Molecular Targeted Therapy<br/>Neoplasms--drug therapy<br/>Receptors, Peptide--metabolism<br/>Receptors, Transforming Growth Factor beta--metabolism